carbamates has been researched along with Erythremia in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this multicentre, open-label, phase II study, 44 patients with polycythaemia vera (PV), unresponsive to the maximum tolerated doses (MTD) of hydroxycarbamide (HC), were treated with Givinostat (50 or 100 mg/d) in combination with MTD of HC." | 2.78 | A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy. ( Barbui, T; Barosi, G; Cilloni, D; Demuth, T; Finazzi, G; Finazzi, MC; Fioritoni, G; Martinelli, V; Musolino, C; Nobile, F; Olimpieri, OM; Pogliani, EM; Rambaldi, A; Ruggeri, M; Sivera, P; Specchia, G; Tollo, SD; Vannucchi, AM, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rambaldi, A | 4 |
| Iurlo, A | 2 |
| Vannucchi, AM | 3 |
| Noble, R | 1 |
| von Bubnoff, N | 2 |
| Guarini, A | 2 |
| Martino, B | 2 |
| Pezzutto, A | 1 |
| Carli, G | 1 |
| De Muro, M | 2 |
| Luciani, S | 2 |
| McMullin, MF | 2 |
| Cambier, N | 1 |
| Marolleau, JP | 1 |
| Mesa, RA | 1 |
| Tibes, R | 1 |
| Pancrazzi, A | 1 |
| Gesullo, F | 1 |
| Bettica, P | 2 |
| Manzoni, S | 2 |
| Di Tollo, S | 2 |
| Chifotides, HT | 1 |
| Bose, P | 1 |
| Verstovsek, S | 1 |
| Ruggeri, M | 2 |
| Martinelli, V | 2 |
| Nogai, A | 1 |
| Rosti, V | 1 |
| Ricco, A | 1 |
| Finazzi, G | 2 |
| Nobile, F | 1 |
| Specchia, G | 1 |
| Pogliani, EM | 1 |
| Olimpieri, OM | 1 |
| Fioritoni, G | 1 |
| Musolino, C | 1 |
| Cilloni, D | 1 |
| Sivera, P | 1 |
| Barosi, G | 1 |
| Finazzi, MC | 1 |
| Tollo, SD | 1 |
| Demuth, T | 1 |
| Barbui, T | 1 |
| Yoshimoto, G | 1 |
| Miyamoto, T | 1 |
| Amaru Calzada, A | 1 |
| Pedrini, O | 1 |
| Leoni, F | 1 |
| Mascagni, P | 1 |
| Introna, M | 1 |
| Golay, J | 1 |
2 reviews available for carbamates and Erythremia
| Article | Year |
|---|---|
Givinostat: an emerging treatment for polycythemia vera.
Topics: Animals; Carbamates; Disease Progression; Histone Deacetylase Inhibitors; Humans; Hydroxyurea; Janus | 2020 |
[Treatment strategy for myeloproliferative neoplasms].
Topics: Adrenal Cortex Hormones; Aspirin; Calreticulin; Carbamates; Clinical Trials as Topic; Drug Therapy, | 2014 |
3 trials available for carbamates and Erythremia
| Article | Year |
|---|---|
Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study.
Topics: Adult; Aged; Aged, 80 and over; Carbamates; Female; Humans; Janus Kinase 2; Male; Maximum Tolerated | 2020 |
Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program.
Topics: Adult; Aged; Carbamates; Female; Follow-Up Studies; Histone Deacetylase Inhibitors; Humans; Male; Mi | 2021 |
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carbamates; Dose-Response Relationship, Drug; Drug Administration Sc | 2013 |
1 other study available for carbamates and Erythremia
| Article | Year |
|---|---|
Givinostat and hydroxyurea synergize in vitro to induce apoptosis of cells from JAK2(V617F) myeloproliferative neoplasm patients.
Topics: Amino Acid Substitution; Antineoplastic Agents; Apoptosis; Blotting, Western; Carbamates; Caspase 3; | 2013 |